Reading Time: 3 minutes Health Canada’s 2017 decision requiring no major changes to product labels for glyphosate herbicide will stand, despite the objections filed in its wake. The federal health department said Friday it has reviewed eight notices of objection received after it released its final re-evaluation decision on glyphosate in April 2017. The objections were filed with Health […] Read more
Health Canada dismisses glyphosate objections
Canola, corn, soy traits to move forward with China approvals
Reading Time: 3 minutes Approvals from China are expected to allow several major trait developments to move ahead in Canadian canola, corn and soybean fields. The Reuters news service on Tuesday reported safety certificate approvals from China’s ministry of agriculture and rural affairs for biotech traits including: Bayer’s 88302, or TruFlex canola, approved in Canada since 2012; BASF’s RF3, […] Read more
Bayer to shed animal health division, others after Monsanto deal
Reading Time: 2 minutes Frankfurt | Reuters — Bayer, the German drugmaker that bought U.S. seed company Monsanto, announced on Thursday the sale of its animal health business and a number of others, around 12,000 job cuts and 3.3 billion euros (C$4.98 billion) in impairments. CEO Werner Baumann is under pressure to boost Bayer’s share price after a drop […] Read more
U.S. judge selects first case in federal glyphosate litigation
Reading Time: 2 minutes Reuters — A U.S. judge overseeing the federal litigation against Bayer’s Monsanto unit over glyphosate-based herbicides allegedly causing cancer on Tuesday selected the first case to be tried in federal court in February 2019. U.S. District Judge Vince Chaabria in San Francisco in an order said the case of California resident Edwin Hardeman will be […] Read more
U.S. judge orders next glyphosate cancer trial for March
Reading Time: 2 minutes Reuters — A California judge on Thursday granted an expedited trial for March in the case of a couple suffering from cancer who sued Bayer’s Monsanto unit, alleging the company’s glyphosate-containing herbicide Roundup caused their disease. The order by Superior Court Judge Ioana Petrou in Oakland, Calif. comes on the heels of a $289 million […] Read more
Bayer CEO says would consider glyphosate settlement depending on costs
Reading Time: 2 minutes St. Louis | Reuters – Bayer AG’s chief executive said this week the company might consider settling lawsuits over Monsanto’s glyphosate-containing weed-killers depending on how high court costs rise, but stressed it remained focused on defending the combined company against claims they cause cancer. Bayer acquired Monsanto this year for $63 billion. “If we can settle […] Read more
U.S. judge affirms Monsanto weed-killer verdict, slashes damages
Reading Time: 2 minutes Reuters – A U.S. judge on Monday affirmed a verdict against Bayer AG unit Monsanto that found its glyphosate-based weed-killers responsible for a man’s terminal cancer, sending the German company’s shares down 8 percent. In a ruling by San Francisco’s Superior Court of California, Judge Suzanne Bolanos said she would slash the punitive damages award […] Read more
Bayer likely to get new trial in glyphosate case
Reading Time: 2 minutes San Francisco | Reuters — Bayer’s Monsanto unit was likely to get a new trial on the US$250 million in punitive damages awarded by a jury to a groundskeeper who alleged the company’s glyphosate-based herbicides, including Roundup, caused his cancer. According to a Wednesday court filing in San Francisco’s Superior Court of California, Judge Suzanne […] Read more
Ag trade flows may change amid trade dispute, Bayer says
Reading Time: 2 minutes Monheim | Reuters — Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities. The head of Bayer’s crop science division told Reuters his company could even benefit if U.S. farmers switched […] Read more
With drugs pipeline in focus, Bayer seen considering cuts
Reading Time: 3 minutes Frankfurt | Reuters — Bayer is considering job cuts and outsourcing as part of a wide-ranging review of drug research and development that will last until at least November, a person familiar with the company told Reuters. The prospect of “very tangible changes” contributed to a decision by key board members to extend the contract […] Read more
A message from April Stewart, Country Guide's Associate Editor
